Medical network - March 13, recently, the pharmaceutical industry's hottest topic is the creation of the new medical insurance directory, updated in this catalogue, amount of medicine health coverage will reach 2535. National medicine is an important part of Chinese traditional medicine, has a long history, distinctive regional and national characteristics, for thousands of years for the breeding of the Chinese nation has made an indelible contribution. Current meters Intranet is to comb the 2017 version of health care for everyone directory what are new national medicine.
According to the planning commission official caliber, 2017 medical insurance directory, proprietary Chinese medicine, western medicine section contains medicine, 2535, 2009 version of the directory 339 new, rising by about 15%. Chinese medicines, including western medicine, 1297, 1238. Look from the expansion rate, expansion rate of the basic flat with 2009, remain at around 16%.
National medicine was strongly support increased 90%
2009 medical insurance directory, only blindly tablets, pills, capsules, granules) is calculated as the national drug, while in the 2017 version as a proprietary Chinese medicine, 20 flavour aloes pill, acbel capsule, negative JieBaiWan three varieties in 09 version as a proprietary Chinese medicine, as in the 2017 edition of national medicine, therefore, the 2017 version of the actual new national medicine for 41, growth reached 90%, proportion is significantly higher than other drugs.
The adjustment of the new medical insurance directory, reflects the countries on the basis of adhere to the "equal emphasis on Chinese and western medicine", strengthening the support of Chinese medicine and ethnic medicine. , according to people club department reported 2017 drug catalogue of Chinese and western medicine and Chinese patent medicine accounted for 51% and 51%, basically unchanged. Can be seen from table 2, the new national medicine there are kinds of exclusive 17, accounted for nearly 42%.
The expansion of national medicine mirrored the unicorn studio founder liu qian for the evaluation of the new medical insurance directory - the government based on the needs of the clinical treatment, considering the different level of economic and health, by expanding the directory to doctor-patient (including all national patient) to provide more choice. The administrative intervention, is essentially a dilute the directory and give the option to the doctor and the market.
New varieties involving multiple fields Tibetan medicine development prospect
From figure 1, you can see, these are the new national medicine 10 treatment field of the communist party of China, and its center cerebrovascular disease medication and qingrejiedu medicine proportion bigger, have accounted for 12%, followed by gastric medicine (drug gastritis, ulcer), the proportion of 10%. Visible above the three therapeutic areas is ethnic medicine area.
The medical insurance directory adjustment, the relevant departments of the Tibetan, Mongolian and the specialized organization medical experts, of Tibetan medicine, Mongolian, d drug review, most new national medicine in medicine, a total of 17 varieties, and the proportion is as high as 42%. Tibetan medicine has distinguishing feature alone, is one of the most complete and most influential national medicine in China. The enterprise has more than hundreds of national medicine, qinghai has more than 20, the Tibet autonomous region has more than 40, gansu, yunnan, sichuan, xinjiang and other places also have unequal distribution. D and Mongolian medicine proportion, the same shall be 29%.
More than 4000 years ago, Tibetan originated in the qinghai-tibet plateau, in the specific geographical environment, full use of the country and the world of traditional medicine is long, formed a complete system and scientific system of nationality medicine. In recent years, as part of the national culture, the factors influencing gradually accepted by people and attention. Tibetan medicine start out of the traditional manual mill production mode, moving towards modernization. This process, Tibetan medicine industry chain have been constantly improve, show broad prospects for development.
Two drug firms varieties into new insurance directory
Dew Tibetan medicine: traditional Tibetan medicine production enterprises
As a traditional Tibetan medicine production enterprises, the dew Tibetan medicine can now produce products up to more than 360 varieties of medicine, which have obtained approval number has 55. At present, the company has 19 patents, has been rated as autonomous region famous brand, China famous trademark, national high-tech enterprise and so on the title. This new national medicine dew Tibetan medicine contained in the product, most have included seventy pearl pill, rinchen often sleep and twenty five donkey blood pill and 12 species into new insurance directory.
According to m, according to data from the network dew Tibetan medicine new twenty five of the 12 national medicine donkey blood pill in the company all the best selling products, nearly two years in China's urban public hospitals, public hospitals at the county level, urban community centre and four towns and townships (hereinafter referred to as the "China public medical institutions") pattern of proprietary Chinese medicine market combined sales increased year by year, sales of 1.09 million yuan in 2015. In addition, in the twenty five donkey blood pill all production enterprise, the dew Tibetan medicine occupy half, market share of up to 85.34% in 2015.
: 金訶 medicine sales increased year by year of 400 million in 2015
Have 金訶 medicine drugs, health care products, Chinese caterpillar fungus, health products, daily life health, characteristics of external treatment 6 major categories of more than 1000 kinds of products, including a total of 68 drug of its kind product, 22 exclusive varieties, exclusive dosage form 6, national drug kinds of 1, 10 OTC varieties, add new into the catalog of 2017 health care 9 varieties, more than 19 varieties of national health insurance directory covers the cardiovascular, gastrointestinal, liver, respiratory, rheumatism bone, skin, and other therapeutic areas, is expected to 金訶 medicine clinical drug sales and have a positive role for the long-term development.
From figure 4, 2013-2015 annuity public medical institutions in China at great medicine combined sales pattern of the traditional market presents the rising trend, in 2015, sales reached 400 million yuan, the company exclusive products satisfied treasures pills (same for medicare catalog products) sales of nearly 200 million, 2015, contributed nearly 50% of the performance for the company. This directory adjustment, we added nine species co, may bring to the company a new round of great power.
Two related proposal Support national drug development
National two sessions are in full swing in 2017, the country during the two sessions this year, Chinese medicine and the folk medicine also become a hot topic. The act of traditional Chinese medicine for the development of national medicine is a major support and promote, embodies the country to the attention of the national medicine. In the act of TCM's background, the national medicine is facing new opportunities. , chairman of the CPPCC national committee, no medicine LeiJuFang advice, to make our national medicine industry as soon as possible to enjoy the dividend policy brought about by the law of traditional Chinese medicine, can adopt mature finishing catalog a batch of examination and approval in time to release a batch to form a system.
A lot of ethnic medicine has its traditional dosage form features. On the basis of its own characteristics, ensuring the efficacy, moderate improvement of dosage form helps to meet the demand of the masses, to further expand the national medicine market. LeiJuFang proposal, in formulating national classic square registration rules, national medicine commonly used dosage forms can be characteristics into account, allowed to retain the characteristic development. Some of these proposals will help ethnic medicine, make its development to the next level.
conclusion
The update of the medical insurance directory, proprietary Chinese medicine, folk medicine is undoubtedly one of the winners. A marked increase in the number of proprietary Chinese medicine varieties, and the two countries strongly encouraged to support development of traditional Chinese medicine is closely linked. National medicine in serious illness and chronic disease prevention and control has the rich experience and good efficacy, safety, is a good complement of modern medicine and traditional Chinese medicine, and has good efficiency, to reduce expenses for medicine accounted for, have very great help to meet the needs of medical system reform. These all make ethnic medicine --, greatly transferred to the new medical insurance directory. Drug was incorporated into medical insurance directory, is the basis of the volume. After the above new national medicine market performance? We wait and see! |
